BPA for prolacta human breastmilk fortifiers for tamc and mamc
Active Blanket Purchase Agreement Awarded Last action
- Contract number
- W81K0222A0010
- Awardee
-
Prolacta Bioscience, Inc. UEI VJUKD4ELEKD6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 29 $1,266,613 obligated
Award facts
- Combined order value
- $1,266,613 Current and potential, with all options
- Last date to order 81% complete
- IDV ceiling 72% used
- $1,750,000.00
- Maximum order
- $250,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency established a Blanket Purchase Agreement with Prolacta Bioscience, Inc. on October 1, 2022, with a $1.75 million ceiling and an ultimate completion date of September 30, 2027, for human breastmilk fortifiers and related neonatal nutritional products for military medical facilities including Tripler Army Medical Center in Hawaii and Madigan Army Medical Center.
Place of performance is City of Industry, California and Bassett, California. The BPA procures pasteurized human milk-based fortifiers, breastmilk supplementation products, and specialized nutritional therapies for premature and extremely low birth weight infants in neonatal intensive care units at military treatment facilities.
Prolacta Bioscience is a for-profit manufacturer specializing exclusively in human milk-derived nutritional products for neonatal populations. The company has issued multiple firm fixed price BPA calls under this vehicle since award. Recent calls include $24,838.78 for breastmilk fortification products at Tripler Army Medical Center (January 12, 2026); $24,971.50 for breastmilk products at Tripler Army Medical Center (November 10, 2025); $35,818.34 for human milk-based nutritional products at Tripler Army Medical Center (October 1, 2025); and $24,246.50 for breastmilk products (July 28, 2025). Ongoing ordering activity through 2025 and into 2026 reflects sustained Defense Health Agency reliance on Prolacta's specialized products to support neonatal care across the military health system.
Task orders
Show all 29
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract W81K0222A0010?
W81K0222A0010 was awarded to Prolacta Bioscience, Inc. by Defense Health Agency (Department of Defense) on October 1, 2022.
How much is contract W81K0222A0010 worth?
Orders under W81K0222A0010 have obligated $1,266,613. W81K0222A0010's own ceiling is $1,750,000. A single order can be worth up to $250,000.
How many orders have been placed under contract W81K0222A0010?
29 orders have been placed under W81K0222A0010, the latest on July 23, 2026.
Who can order from contract W81K0222A0010?
W81K0222A0010 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV